A comprehensive review on Drug Product registration and approval process in Brunei Darussalam and Ukraine
The drug and drug product registration and approval processes vary in each country which is regularized by the statutory drug regulatory agencies. This review gives detailed information on the regulatory requirements for drug product registration in Brunei Darussalam and Ukraine. Departments working under the administration of Ministry of Health are working for the drug product registration and approval in both the countries, respectively. Dossier submission is a preliminary requirement for any pharmaceutical product to be marketed. The specifications for Dossier in both the countries are likely to be similar but they adhere to different guidelines for Dossier requirements. The timelines for drug product registration depends upon the type of product and the adequacy of the data submitted to the authority. A comprehensive study of submission requirements, registration process and role of drug regulating departments of Brunei Darussalam and Ukraine will help to understand the regulatory procedures of both the countries in a precise manner.
2. WHO. Pharmaceutical System BRUNEI DARUSSALAM [Internet]. Western Pacific Region -WHO; 2017 [cited 2020 Aug 31]. Available from:
3. Cratia. State Registration of Medicines and Active Pharmaceuticals [Internet]. Ukraine: Cratia [Date Unknown] [cited 2020 Apr 06]. Available from:
4. MoH Brunei Darussalam. Guideline to Application for Registration of Medicinal Products [Internet]. Brunei Darussalam: Department of Pharmaceutical Services; Dec 2012 [cited 2020 Mar 30]. Available from: http://www.moh.gov.bn/SiteCollectionDocuments/PDF/Guidelines/Guide%20to%20Application%20for%20registration%20of%20Medicinal%20Products.pdf
5. Ravi G, Reddy RM, Krishnaveni Reddy D, Gupta NVK. Comparison of Marketing Authorisation and its Requirements for Brunei Darussalam and Indonesia. Journal of Clinical Studies [Internet]. [cited 2020 March 30]; 7(1): 36-41. Available from:
6. MoH Brunei Darussalam. Application Checklist for Drug Registration [Internet]. Brunei Darussalam: Department of Pharmaceutical Services, Dec 2012 [cited 2020 2020 March 30]. Available from:
7. Srilakshmi, CH. Vijay Kumar K, Prabhar AE, Nadendla R. Comparison Study of Marketing Authorization and Regulatory Requirements of Generic Drugs in Brunei Darussalam and Indonesia. International Journal of Pharma And Chemical Research [Internet]. 2017 [cited 2020 March 30]; 3(3): 618-634. Available from:
8. WHO. The health system and policy monitor: regulation [Internet]. Ukraine European Region: WHO; 2017 Feb [cited 2020 Aug 31]. Available from:
9. Legislation of Ukraine. On approval of the Regulation on the State Service of Ukraine for Medicines and Drug Control [Internet]. [Place Unknown], [Publisher Unknown] 2015 Aug 12 [cited 2020 Aug 31]. Available from:
10. Yuriy Gamazin. Slideshare – Ukranian State Expert Center MoH of Ukraine [Internet]. Moscow, Yuriy Gamazin; 2013 May [cited 2020 Aug 31]. Available from:
11. State Sites of Ukraine. State Service of Ukraine on Medicines and Drugs Control [Internet]. [Place Unknown], State Service of Ukraine on Medicines and Drug Control; 2020 Jun 10 [cited 2020 Aug 31]. Available from:
12. State Registration of Medicinal Products in Ukraine [Internet]. [Place Unknown], MSP Agile IP Group, [Date Unknown] [cited 2020 Apr 06]. Available from:
13. Volodymyr Gurlov, Registration of Drugs in Ukraine: Procedure, Required Documents and Terms [Internet]. [Place Unknown], Pravova Dopomoga; 2013 Feb 01 [cited 2020 Aug 31]. Available from: https://pravdop.com/en/publications/kommentarii-zakonodatelstva/registraciya-lekarstvennih-sredstv-v-ukraine-poryadok-dokumenti-sroki/
14. Pharmaceuticals Export Promotion Council of India. Regulatory and Market Profile of Ukraine [Internet]. [Place Unknown], Pharmexcil, [Date Unknown, cited 2020 April 06]. Available from:
15. Ukraine. Import of drugs to Ukraine: state registration [Internet]. [Place Unknown] ; 2011 [cited 2020 Aug 31]. Available from:
16. European Medicines Agency. Presentation and format of the Dossier (CTD) [Internet]. Europe: EMA; 2006 Jun [cited 2020 April 07]. Available from:
17. ICH. ICH Harmonized Guideline [Internet]. ICH; 2016 Jun 15 [cited 2020 Aug 24]. Available from: https://database.ich.org/sites/default/files/M4_R4__Guideline.pdf
18. Praneetha K, Prakash B, Umasankar K, Alagusundaram M, Jayachandra Reddy P. Study on the Regulatory Requirements for Registration of Pharmaceuticals for Human Use in Common Wealth of Independent States. Journal of Science [Internet]. 2014 [cited 2020 Apr 06]; 4(8): 486-504. Available from:
19. Patel P, Badjatya JK, Hinge M. Comparative study of Regulatory requirements of Drug Product in Emerging market. Int J Drug Reg Affairs [Internet]. 2019 Sep. 15 [cited 2020 Sep. 17];7(3):48-2. Available from:
20. The ASEAN Secretariat Jakarta. ASEAN Common Technical Dossier (ACTD) [Internet]. Jakarta: ASEAN Secretariat; 2016 Dec [cited 2020 Aug 31]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM